------Topical Antifungal Prescribing for Medicare Part D Beneficiaries - United States, 2021

This study found that enough topical antifungal prescriptions were written for approximately one of every eight Medicare Part D beneficiaries in 2021, and 10% of antifungal prescribers prescribed nearly one half of these medications. In the setting of emerging antimicrobial resistance, these findings highlight the importance of expanding efforts to understand current prescribing practices while encouraging judicious prescribing by clinicians and providing patient education about proper use.PMID:38206854 | PMC:PMC10794060 | DOI:10.15585/mmwr.mm7301a1

Source: MMWR Morb Mortal Wkl... - January 11, 2024 Category: Epidemiology Authors: Kaitlin Benedict Dallas J Smith Tom Chiller Shari R Lipner Jeremy A W Gold Source Type: research